The Barpeta
Obstetric & Gynaecological Society

Department of Obstetrics and Gynaecology,
Fakhruddin Ali Ahmed Medical College, Jania Road, Barpeta.Assam. 
(Registered under Societies Registration Act, XXI of 1860)

Measles postexposure prophylaxis (July 2013)

Guidelines on prevention of measles, mumps, and rubella were issues by the Advisory Committee on Immunization Practices in June 2013. These guidelines expand recommendations for use of immune globulin administered intramuscularly (IGIM) to include infants aged birth to six months exposed to measles, increase the recommended dose of IGIM for immunocompetent individuals, and recommend use of immune globulin administered intravenously (IGIV) for severely immunocompromised individuals and pregnant women without evidence of measles immunity who are exposed to measles

Obesity increases the risk of spontaneous preterm birth (July 2013)

Obesity is a well-established risk factor for medically-indicated preterm delivery. A population-based cohort study from Sweden including over 1.5 million singleton deliveries confirmed that overweight and obese women were not only at increased risk for medically-indicated preterm deliveries at all gestational ages, but also observed a significant dose-response relationship between severity of obesity and risk of spontaneous extremely preterm birth (22 to 27 weeks). These data support the importance of preconceptional weight loss for obese women

Support for screening for and treating gestational diabetes mellitus (July 2013)

In a 2013 systematic review and meta-analysis of randomized trials for the US Preventive Services Task Force, appropriate management of gestational diabetes mellitus (nutritional therapy, self blood glucose monitoring, and administration of insulin if target blood glucose concentrations are not met with diet alone) resulted in reductions in  preeclampsia, birthweight >4000 grams, and shoulder dystocia. This analysis provides additional support for screening and treatment of gestational diabetes mellitus

Levonorgestrel-releasing intrauterine device for women on anticoagulants (December 2013)

Women on anticoagulants are at increased risk of heavy menstrual bleeding. The levonorgestrel-releasing-intrauterine device (LNg-IUD), which is beneficial in reducing menstrual flow in women with heavy bleeding, also appears to be effective in women who are being treated with anticoagulants. In a prospective study of 33 women with thrombophilia and/or history of thrombosis who initiated LNg-IUD use, oral anticoagulant users had similar bleeding patterns to nonusers during the first 12 months after LNg-IUD insertion . Three-quarters of the women developed amenorrhea or infrequent bleeding and no women experienced frequent or prolonged bleeding




1 2 3

Official Journal of Barpeta Obstetric & Gynaecological Society, Volume 1, Issue 1

Recent updates :